In a subgroup analysis within the same population, consistent with its role as a thrombophilic biomarker, high FVIIa–AT plasma levels also correlated directly with FXa generation and, notably, the characteristics of hypercoagulability related to FVIIa–AT were specifically detectable in the initiation phase of coagulation [32]. The gene discussed is F10; the disease is thrombophilia.